CytoSorbents Reports Full Third Quarter 2021 Financial and O

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

Related Keywords

Germany , United States , Thailand , Belgium , Italy , Luxembourg , Brussels , Bruxelles Capitale , Spain , Ukraine , Barcelona , Comunidad Autonoma De Cataluna , German , Eric Kim , Phillip Chan , Twitter , Material Command , European Association For Cardio , Development Expenses , European Union , Us Army , Facebook , Ethics Committee , Cytosorbents Corporation , National Heart , Blood Institute , European Society Of Organ Transplantation , Us Department Of Health , Human Services , National Institutes Of Health , International Symposium Of Intensive Care Medicine , Us Air , Company Form , European Association Of Cardio , Corporate Communications , International Symposium On Intensive Care Emergency Medicine , Timely Antithrombotic Removal , Breakthrough Designation , Direct Oral Anticoagulants , International Symposium , Intensive Care , Emergency Medicine , European Association , Cardio Thoracic Surgery , Organ Perfusion System , European Society , Organ Transplantation , Full Year , Chief Executive Officer , Device Designation , Cytosorb Therapy , Use Authorization , Intensive Care Medicine , Thoracic Surgery , Bridge Bank , New Jersey , Call Details , Investor Relations , Sorbents Corporation , Antithrombotic Removal System , Timely Antithrombotic Removal Ticagrelor , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Relations Contact ,